Clinical trial

CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients

Name
Z-2021070
Description
Major surgery induces a systemic inflammatory response, which can influence the post-operative morbidity, such as coagulation disorders and post-operative muscle weakness, hampering early recovery after surgery. Single administration of high dose corticosteroids is known to reduce this inflammatory response and could possibly improve the post-operative outcome. The CORTERAS study will evaluate the effect of administration of corticosteroids, as compared to no corticosteroids, on postoperative muscle weakness and quality of recovery after surgery in elderly patients.
Trial arms
Trial start
2022-02-03
Estimated PCD
2025-11-01
Trial end
2025-12-01
Status
Recruiting
Phase
Early phase I
Treatment
Methylprednisolone
250 mg Methylprednisolone made up with 100 ml NaCl0,9% as an IV injection at the induction of anaesthesia but before surgery. If CPB is required an additional dose in 100 ml will be given.
Arms:
Methylprednisolone
NaCl 0.9%
100 ml NaCl0,9% as an IV injection at the induction of anaesthesia but before surgery. If CPB is required an additional 100ml will be given.
Arms:
Placebo
Size
672
Primary endpoint
Post operative muscle weakness
Pre-operative and Post operative day 1
Eligibility criteria
Inclusion Criteria: * Aged 60 years or older. * Scheduled for one of the predefined surgical procedures: * off-pump coronary bypass surgery * on-pump coronary bypass surgery * aortic and mitral valve replacement * laparoscopic hemicolectomies * thoracoscopic lung resections * femoral popliteal and tibial bypass surgery and femoral profundoplasty * laparoscopic radical prostatectomies Exclusion Criteria: * Lack of informed consent or inability to give informed consent. * Severe postoperative nausea \& vomiting (PONV), needing corticosteroids as PONV prophylaxis. * Urgent, not elective surgery * Hypersensitivity or known allergic reactions to methylprednisolone * Preoperative systemic use of steroids: * Including, but not limited to, the use of corticosteroids \> 4 weeks before surgery of at least 4 mg methylprednisolone equivalents. * Excluding inhalational and topical steroids * Preexisting muscle disease o Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 672, 'type': 'ESTIMATED'}}
Updated at
2024-04-11

1 organization

1 product

1 drug

3 indications

Indication
Weakness
Indication
Muscle